All Stories

  1. Update on GH therapy in adults
  2. MECHANISMS IN ENDOCRINOLOGY: Clinical and pharmacogenetic aspects of the growth hormone receptor polymorphism
  3. Chronic l-menthol-induced browning of white adipose tissue hypothesis: A putative therapeutic regime for combating obesity and improving metabolic health
  4. A review on the diagnosis and treatment of patients with clinically nonfunctioning pituitary adenoma by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism
  5. Challenges in the diagnosis and management of acromegaly: a focus on comorbidities
  6. Recommendations of the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism for the diagnosis of Cushing’s disease in Brazil
  7. Long-Term Remission of Acromegaly after Octreotide withdrawal is an Uncommon and Frequently Unsustainable Event
  8. MANAGEMENT OF ENDOCRINE DISEASE: Acromegaly and cancer: an old debate revisited
  9. Endoscopic versus microscopic transsphenoidal surgery in the treatment of pituitary tumors: systematic review and meta-analysis of randomized and non-randomized controlled trials
  10. Growth hormone, insulin-like growth factor system and carcinogenesis
  11. Sarcopenia in COPD: relationship with COPD severity and prognosis
  12. In the land of giants: the legacy of José Dantas de Souza Leite
  13. Acromegaly and cancer
  14. Heterogeneous Genetic Background of the Association of Pheochromocytoma/Paraganglioma and Pituitary Adenoma: Results From a Large Patient Cohort
  15. Extracellular Water and Blood Pressure in Adults with Growth Hormone (GH) Deficiency: A Genotype-Phenotype Association Study
  16. Whole Exome Sequencing of Extreme Morbid Obesity Patients: Translational Implications for Obesity and Related Disorders
  17. Osteocalcin, energy and glucose metabolism
  18. Bone mineral density, vitamin D, and nutritional status of children submitted to hematopoietic stem cell transplantation
  19. Vitamin D deficiency in children and adolescents submitted to hematopoietic stem cell transplantation
  20. Acromegaly and pregnancy: a prospective study
  21. Reappraisal of serum insulin-like growth factor-I (IGF-1) measurement in the detection of isolated and combined growth hormone deficiency (GHD) during the transition period
  22. Endocrine Hypertension
  23. Are patients in remission from Cushing's syndrome mentally healthy?
  24. Pituitary adenoma and phaeochromocytoma/paraganglioma - a novel syndrome with a heterogeneous genetic background
  25. Genetic studies in a coexistence of acromegaly, pheochromocytoma, gastrointestinal stromal tumor (GIST) and thyroid follicular adenoma
  26. Evidence for Higher Success Rates and Successful Treatment Earlier in Graves' Disease with Higher Radioactive Iodine Doses
  27. Evidence for Higher Success Rates and Successful Treatment Earlier in Graves´ Disease with Higher Radioiodine Doses
  28. Comparison of two dose regimens of growth hormone (GH) with different target IGF-1 levels on glucose metabolism, lipid profile, cardiovascular function and anthropometric parameters in gh-deficient adults
  29. Recomendações do Departamento de Neuroendocrinologia da Sociedade Brasileira de Endocrinologia e Metabologia para o Diagnóstico e Tratamento da Acromegalia no Brasil
  30. A comparison of cabergoline and bromocriptine on the risk of valvular heart disease in patients with prolactinomas
  31. Recomendações do Departamento de Neuroendocrinologia da Sociedade Brasileira de Endocrinologia e Metabologia para o diagnóstico e tratamento da acromegalia no Brasil
  32. Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis
  33. Application of genetic testing to define the surgical approach in a sporadic case of multiple endocrine neoplasia type 1
  34. Skeletal microstructural abnormalities in postmenopausal women with chronic obstructive pulmonary disease
  35. Management of prolactinomas in Brazil: an electronic survey
  36. Growth Hormone Deficiency: Transition from Adolescence to Adulthood. Highlights from a Latin-American Serono Symposia International Foundation Conference
  37. Decrease in leptin production by the adipose tissue in obesity associated with severe metabolic syndrome
  38. Androgênios séricos e densidade mineral óssea em mulheres ooforectomizadas e não ooforectomizadas na pós-menopausa
  39. Efeitos endócrinos e metabólicos das drogas antiepilépticas
  40. Performance of computed tomographic colonography for the screening of colorectal polyp in acromegalic patients: a prospective study
  41. Influence of the Exon 3-Deleted/Full-Length Growth Hormone (GH) Receptor Polymorphism on the Response to GH Replacement Therapy in Adults with Severe GH Deficiency
  42. Efeitos endócrinos e metabólicos dos antiepilépticos
  43. Tratamento com hormônio de crescimento em crianças com baixa estatura nascidas pequenas para a idade gestacional
  44. Eficácia, segurança e aderência ao tratamento de longo prazo com hormônio de crescimento (GH) em adultos com deficiência de GH
  45. Bone density and bone turnover markers in patients with epilepsy on chronic antiepileptic drug therapy
  46. Insulin-Like Growth Factor-1, Leptin, Body Composition, and Clinical Status Interactions in Children with Cystic Fibrosis
  47. Resultados do tratamento cirúrgico na acromegalia com um único neurocirurgião e meta-análise cumulativa
  48. Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs
  49. Sobre o universo hormonal, música e encantamento
  50. Deficiência de GH em adultos: resultados do estudo multicêntrico brasileiro
  51. Molecular heterogeneity of human GH: From basic research to clinical implications
  52. Insulinoma Maligno Produzindo Hipoglicemia
  53. Growth hormone (GH) replacement therapy in GH-deficient women during pregnancy
  54. The Cerebrospinal Fluid/Serum Leptin Ratio during Pharmacological Therapy for Obesity
  55. O Laboratório no Diagnóstico e Seguimento da Acromegalia
  56. Changes in Non-22-Kilodalton (kDa) Isoforms of Growth Hormone (GH) after Administration of 22-kDa Recombinant Human GH in Trained Adult Males1
  57. Genética molecular do eixo GH-IGF1
  58. The Response of Molecular Isoforms of Growth Hormone to Acute Exercise in Trained Adult Males1
  59. Concomitant Presentation of Hashimoto's Thyroiditis and Maltoma of the Thyroid in a Twenty-Year-Old Man with a Rapidly Growing Mass in the Neck
  60. Growth hormone isoforms in newborns and postpartum women
  61. Cloning of Two Novel Growth Hormone Transcripts Expressed in Human Placenta1
  62. Cloning of Two Novel Growth Hormone Transcripts Expressed in Human Placenta
  63. Increased Proportion of Circulating Non-22-Kilodalton Growth Hormone Isoforms in Short Children: A Possible Mechanism for Growth Failure1
  64. Circulating non-22 kDa growth hormone isoforms in healthy children of normal stature: relation to height, body mass and pubertal development
  65. Increased Proportion of Circulating Non-22-Kilodalton Growth Hormone Isoforms in Short Children: A Possible Mechanism for Growth Failure
  66. Circulating Non-22-Kilodalton Growth Hormone Isoforms in Acromegalic Men before and after Transsphenoidal Surgery1
  67. Circulating Non-22-Kilodalton Growth Hormone Isoforms in Acromegalic Men before and after Transsphenoidal Surgery
  68. Mechanisms of Growth Failure in Non-Growth-Hormone Deficient Children of Short Stature